| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF620 ZNF717 PLAGL1 ZNF397 ZNF101 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 5.19e-07 | 1412 | 36 | 13 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF620 ZNF717 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 7.54e-07 | 1459 | 36 | 13 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF717 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 7.42e-06 | 1244 | 36 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF717 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 9.10e-06 | 1271 | 36 | 11 | GO:0000987 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.85e-03 | 44 | 36 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.67e-03 | 188 | 36 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 4.81e-03 | 190 | 36 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | peptidase activity | 6.04e-03 | 654 | 36 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 6.09e-03 | 207 | 36 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 6.51e-03 | 212 | 36 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 6.68e-03 | 68 | 36 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 6.87e-03 | 69 | 36 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 7.25e-03 | 430 | 36 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 7.26e-03 | 71 | 36 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | p53 binding | 8.49e-03 | 77 | 36 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.00e-02 | 84 | 36 | 2 | GO:0003684 | |
| GeneOntologyCellularComponent | Golgi lumen | 8.69e-04 | 109 | 36 | 3 | GO:0005796 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF804B ZNF331 ZNF189 | 4.12e-11 | 775 | 35 | 14 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF804B ZNF331 ZNF189 | 4.26e-11 | 777 | 35 | 14 | PS00028 |
| Domain | Znf_C2H2-like | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF804B ZNF331 ZNF189 | 5.87e-11 | 796 | 35 | 14 | IPR015880 |
| Domain | Znf_C2H2 | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF804B ZNF331 ZNF189 | 6.82e-11 | 805 | 35 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF804B ZNF331 ZNF189 | 7.16e-11 | 808 | 35 | 14 | SM00355 |
| Domain | zf-C2H2 | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 1.57e-10 | 693 | 35 | 13 | PF00096 |
| Domain | - | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 1.87e-09 | 679 | 35 | 12 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF620 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 2.40e-09 | 694 | 35 | 12 | IPR013087 |
| Domain | EGF | 9.79e-09 | 235 | 35 | 8 | SM00181 | |
| Domain | EGF-like_dom | 3.37e-07 | 249 | 35 | 7 | IPR000742 | |
| Domain | Growth_fac_rcpt_ | 4.10e-07 | 156 | 35 | 6 | IPR009030 | |
| Domain | zf-C2H2_6 | 1.59e-06 | 314 | 35 | 7 | PF13912 | |
| Domain | KRAB | 3.80e-06 | 358 | 35 | 7 | PS50805 | |
| Domain | KRAB | 3.80e-06 | 358 | 35 | 7 | PF01352 | |
| Domain | KRAB | 4.63e-06 | 369 | 35 | 7 | SM00349 | |
| Domain | KRAB | 4.72e-06 | 370 | 35 | 7 | IPR001909 | |
| Domain | Furin_repeat | 4.83e-06 | 18 | 35 | 3 | IPR006212 | |
| Domain | FU | 4.83e-06 | 18 | 35 | 3 | SM00261 | |
| Domain | EGF_LAM_2 | 2.36e-05 | 30 | 35 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.36e-05 | 30 | 35 | 3 | PS01248 | |
| Domain | Laminin_aI | 3.40e-05 | 5 | 35 | 2 | IPR009254 | |
| Domain | Laminin_I | 3.40e-05 | 5 | 35 | 2 | PF06008 | |
| Domain | Laminin_II | 3.40e-05 | 5 | 35 | 2 | PF06009 | |
| Domain | Laminin_domII | 3.40e-05 | 5 | 35 | 2 | IPR010307 | |
| Domain | Laminin_EGF | 3.79e-05 | 35 | 35 | 3 | PF00053 | |
| Domain | EGF_Lam | 3.79e-05 | 35 | 35 | 3 | SM00180 | |
| Domain | LAM_G_DOMAIN | 4.86e-05 | 38 | 35 | 3 | PS50025 | |
| Domain | Laminin_EGF | 4.86e-05 | 38 | 35 | 3 | IPR002049 | |
| Domain | GF_recep_IV | 5.09e-05 | 6 | 35 | 2 | PF14843 | |
| Domain | GF_recep_IV | 5.09e-05 | 6 | 35 | 2 | IPR032778 | |
| Domain | Peptidase_S8_Asp-AS | 5.09e-05 | 6 | 35 | 2 | IPR023827 | |
| Domain | Laminin_G_2 | 5.68e-05 | 40 | 35 | 3 | PF02210 | |
| Domain | PrprotnconvertsP | 7.12e-05 | 7 | 35 | 2 | IPR002884 | |
| Domain | P_proprotein | 7.12e-05 | 7 | 35 | 2 | PF01483 | |
| Domain | S8_pro-domain | 7.12e-05 | 7 | 35 | 2 | IPR032815 | |
| Domain | - | 7.12e-05 | 7 | 35 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 7.12e-05 | 7 | 35 | 2 | PF16470 | |
| Domain | LamG | 7.57e-05 | 44 | 35 | 3 | SM00282 | |
| Domain | LAMININ_IVA | 9.49e-05 | 8 | 35 | 2 | PS51115 | |
| Domain | Laminin_B | 9.49e-05 | 8 | 35 | 2 | PF00052 | |
| Domain | LamB | 9.49e-05 | 8 | 35 | 2 | SM00281 | |
| Domain | Laminin_IV | 9.49e-05 | 8 | 35 | 2 | IPR000034 | |
| Domain | EGF_1 | 1.06e-04 | 255 | 35 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.18e-04 | 261 | 35 | 5 | IPR013032 | |
| Domain | Peptidase_S8_His-AS | 1.22e-04 | 9 | 35 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 1.22e-04 | 9 | 35 | 2 | IPR023828 | |
| Domain | EGF_2 | 1.27e-04 | 265 | 35 | 5 | PS01186 | |
| Domain | Peptidase_S8_subtilisin-rel | 1.52e-04 | 10 | 35 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 1.52e-04 | 10 | 35 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 1.52e-04 | 10 | 35 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 1.52e-04 | 10 | 35 | 2 | PS00138 | |
| Domain | Laminin_G | 1.73e-04 | 58 | 35 | 3 | IPR001791 | |
| Domain | Peptidase_S8 | 1.86e-04 | 11 | 35 | 2 | PF00082 | |
| Domain | - | 1.86e-04 | 11 | 35 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 1.86e-04 | 11 | 35 | 2 | IPR000209 | |
| Domain | PLAC | 3.06e-04 | 14 | 35 | 2 | PF08686 | |
| Domain | - | 3.43e-04 | 73 | 35 | 3 | 2.60.120.260 | |
| Domain | LAMININ_NTER | 4.03e-04 | 16 | 35 | 2 | PS51117 | |
| Domain | Laminin_N | 4.03e-04 | 16 | 35 | 2 | PF00055 | |
| Domain | Laminin_N | 4.03e-04 | 16 | 35 | 2 | IPR008211 | |
| Domain | LamNT | 4.03e-04 | 16 | 35 | 2 | SM00136 | |
| Domain | Propept_inh | 4.56e-04 | 17 | 35 | 2 | IPR009020 | |
| Domain | PLAC | 5.72e-04 | 19 | 35 | 2 | IPR010909 | |
| Domain | PLAC | 5.72e-04 | 19 | 35 | 2 | PS50900 | |
| Domain | Galactose-bd-like | 7.19e-04 | 94 | 35 | 3 | IPR008979 | |
| Domain | - | 7.42e-04 | 95 | 35 | 3 | 2.60.120.200 | |
| Domain | Ephrin_rec_like | 9.96e-04 | 25 | 35 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 9.96e-04 | 25 | 35 | 2 | IPR011641 | |
| Domain | SET | 2.67e-03 | 41 | 35 | 2 | PF00856 | |
| Domain | SET | 3.35e-03 | 46 | 35 | 2 | SM00317 | |
| Domain | CUB | 3.80e-03 | 49 | 35 | 2 | PF00431 | |
| Domain | SET_dom | 3.95e-03 | 50 | 35 | 2 | IPR001214 | |
| Domain | CUB | 3.95e-03 | 50 | 35 | 2 | SM00042 | |
| Domain | SET | 3.95e-03 | 50 | 35 | 2 | PS50280 | |
| Domain | - | 4.27e-03 | 52 | 35 | 2 | 2.60.120.290 | |
| Domain | CUB | 4.43e-03 | 53 | 35 | 2 | PS01180 | |
| Domain | CUB_dom | 5.10e-03 | 57 | 35 | 2 | IPR000859 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | BLM ZNF620 ZNF717 RSPO3 PLAGL1 ZNF101 ZNF25 ZNF665 ZNF540 SMYD2 ZNF804B ZNF331 ZNF189 | 6.97e-07 | 1387 | 28 | 13 | M734 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.81e-04 | 56 | 28 | 3 | MM17236 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 2.07e-04 | 11 | 28 | 2 | MM15559 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M158 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 5.99e-04 | 768 | 28 | 7 | MM14851 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 6.23e-04 | 1022 | 28 | 8 | MM15436 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 6.37e-04 | 19 | 28 | 2 | M27839 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 1.11e-03 | 25 | 28 | 2 | MM15562 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.60e-03 | 30 | 28 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.60e-03 | 30 | 28 | 2 | M27216 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.71e-03 | 31 | 28 | 2 | MM1343 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.93e-03 | 33 | 28 | 2 | M39503 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.93e-03 | 33 | 28 | 2 | M6220 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 2.05e-03 | 34 | 28 | 2 | M27842 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.41e-03 | 136 | 28 | 3 | MM14848 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.97e-03 | 41 | 28 | 2 | M27778 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 3.73e-03 | 46 | 28 | 2 | MM14933 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.73e-03 | 46 | 28 | 2 | M239 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 1.98e-07 | 49 | 36 | 4 | 9630514 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8335106 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8939648 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8468318 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18061232 | ||
| Pubmed | Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. | 3.12e-06 | 3 | 36 | 2 | 11063880 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 37422930 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 8670066 | ||
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | 6.24e-06 | 4 | 36 | 2 | 16829522 | |
| Pubmed | Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. | 6.24e-06 | 4 | 36 | 2 | 8615794 | |
| Pubmed | The proprotein convertases furin and PACE4 play a significant role in tumor progression. | 6.24e-06 | 4 | 36 | 2 | 10900462 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 12787574 | ||
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | 6.24e-06 | 4 | 36 | 2 | 9521771 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 11969289 | ||
| Pubmed | Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. | 1.04e-05 | 5 | 36 | 2 | 9242664 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 11829758 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 11380615 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 18664504 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 1.04e-05 | 5 | 36 | 2 | 9415429 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 1.04e-05 | 5 | 36 | 2 | 9389447 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 9291583 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 9597096 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 16135528 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 8940009 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 2.18e-05 | 7 | 36 | 2 | 9004048 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 10409610 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 7819324 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 9852162 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 7782070 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 8872465 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 10757814 | ||
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 2.91e-05 | 8 | 36 | 2 | 9885250 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 10037747 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 23775089 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 3.73e-05 | 9 | 36 | 2 | 18343183 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 8698813 | ||
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 3.73e-05 | 9 | 36 | 2 | 21805236 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 21805237 | ||
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 3.73e-05 | 9 | 36 | 2 | 22679642 | |
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 16163737 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 9034910 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 5.70e-05 | 11 | 36 | 2 | 21524702 | |
| Pubmed | 6.83e-05 | 12 | 36 | 2 | 16750824 | ||
| Pubmed | 6.83e-05 | 12 | 36 | 2 | 9396756 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 8.07e-05 | 13 | 36 | 2 | 21900571 | |
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 9151674 | ||
| Pubmed | Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. | 1.08e-04 | 15 | 36 | 2 | 23583980 | |
| Pubmed | 1.08e-04 | 15 | 36 | 2 | 9264260 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.08e-04 | 15 | 36 | 2 | 15895400 | |
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 1.24e-04 | 16 | 36 | 2 | 20876279 | |
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 17601529 | ||
| Pubmed | 1.58e-04 | 18 | 36 | 2 | 11311202 | ||
| Pubmed | 1.96e-04 | 20 | 36 | 2 | 23918928 | ||
| Pubmed | 1.96e-04 | 20 | 36 | 2 | 22911573 | ||
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 2.16e-04 | 21 | 36 | 2 | 22959728 | |
| Pubmed | Chromosomal localization of the genes for five zinc finger proteins expressed in mouse lens. | 2.38e-04 | 22 | 36 | 2 | 7590745 | |
| Pubmed | 2.38e-04 | 22 | 36 | 2 | 28963472 | ||
| Pubmed | 2.38e-04 | 22 | 36 | 2 | 1505991 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.97e-04 | 125 | 36 | 3 | 32891193 | |
| Pubmed | 3.33e-04 | 26 | 36 | 2 | 24742657 | ||
| Pubmed | 4.16e-04 | 29 | 36 | 2 | 22613833 | ||
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 5.72e-04 | 34 | 36 | 2 | 19060911 | |
| Pubmed | 6.91e-04 | 167 | 36 | 3 | 22159717 | ||
| Pubmed | 7.54e-04 | 39 | 36 | 2 | 21909109 | ||
| Pubmed | 7.93e-04 | 40 | 36 | 2 | 27068110 | ||
| Pubmed | 8.72e-04 | 181 | 36 | 3 | 37372979 | ||
| Cytoband | 19q13.12 | 1.48e-03 | 72 | 36 | 2 | 19q13.12 | |
| Cytoband | 19q13.42 | 4.36e-03 | 125 | 36 | 2 | 19q13.42 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q22 | 4.50e-03 | 127 | 36 | 2 | chr6q22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF620 ZNF717 PLAGL1 ZNF397 ZNF101 ZNF763 ZNF25 TSHZ2 ZNF665 ZNF540 ZFP62 ZNF260 ZNF331 ZNF189 | 1.73e-12 | 718 | 30 | 14 | 28 |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 9.51e-05 | 9 | 30 | 2 | 973 | |
| GeneFamily | Laminin subunits | 1.74e-04 | 12 | 30 | 2 | 626 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.44e-03 | 34 | 30 | 2 | 487 | |
| Coexpression | NABA_MATRISOME | 6.55e-06 | 1008 | 36 | 9 | MM17056 | |
| Coexpression | NABA_MATRISOME | 7.55e-06 | 1026 | 36 | 9 | M5889 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-07 | 193 | 36 | 5 | c5bd0ed6f57459e54d2463318e8d9b1879718e63 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 5.04e-07 | 196 | 36 | 5 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-07 | 199 | 36 | 5 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.93e-06 | 163 | 36 | 4 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.93e-06 | 163 | 36 | 4 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 171 | 36 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 171 | 36 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-05 | 177 | 36 | 4 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-05 | 177 | 36 | 4 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 185 | 36 | 4 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 185 | 36 | 4 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.53e-05 | 187 | 36 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 190 | 36 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 190 | 36 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 190 | 36 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.74e-05 | 193 | 36 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.77e-05 | 194 | 36 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 194 | 36 | 4 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.81e-05 | 195 | 36 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 197 | 36 | 4 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.88e-05 | 197 | 36 | 4 | d9021bab82403e566ec10f78acb227c0f80b88fe | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.88e-05 | 197 | 36 | 4 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 198 | 36 | 4 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 198 | 36 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Epithelial-Epithelial-D_(Clara-Club_cells)|Epithelial / shred on cell class and cell subclass (v4) | 1.33e-04 | 123 | 36 | 3 | caa1576f1b5eb592d522be61c090ac444e277ac5 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.37e-04 | 124 | 36 | 3 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.64e-04 | 132 | 36 | 3 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-04 | 141 | 36 | 3 | 40ef6d792e11fe10963d64eb0b606b90556c1a70 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 156 | 36 | 3 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 156 | 36 | 3 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-04 | 156 | 36 | 3 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-04 | 156 | 36 | 3 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 159 | 36 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-04 | 161 | 36 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-04 | 161 | 36 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-04 | 161 | 36 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 162 | 36 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 162 | 36 | 3 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 162 | 36 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 162 | 36 | 3 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 3.11e-04 | 164 | 36 | 3 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 164 | 36 | 3 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.22e-04 | 166 | 36 | 3 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 167 | 36 | 3 | 5d89f5bcd0aaa772c1d09c2cc46fbfe0a90f9f12 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.28e-04 | 167 | 36 | 3 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 167 | 36 | 3 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 167 | 36 | 3 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 3.34e-04 | 168 | 36 | 3 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 169 | 36 | 3 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 169 | 36 | 3 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.39e-04 | 169 | 36 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-04 | 169 | 36 | 3 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 169 | 36 | 3 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-04 | 169 | 36 | 3 | 559e98216720e4babf0b0941100f1b485c35b11b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 170 | 36 | 3 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-04 | 170 | 36 | 3 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.45e-04 | 170 | 36 | 3 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 171 | 36 | 3 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 171 | 36 | 3 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 171 | 36 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 171 | 36 | 3 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 171 | 36 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 171 | 36 | 3 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-04 | 172 | 36 | 3 | fb8ab2576b5c38db63573a3bf46b8d9d634c4999 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 3.57e-04 | 172 | 36 | 3 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 173 | 36 | 3 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 173 | 36 | 3 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-04 | 174 | 36 | 3 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-04 | 174 | 36 | 3 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 175 | 36 | 3 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.76e-04 | 175 | 36 | 3 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 175 | 36 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 175 | 36 | 3 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 175 | 36 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 177 | 36 | 3 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.88e-04 | 177 | 36 | 3 | e68ad19963a3d8917dfdb81127a41c4fcbe61dd5 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.95e-04 | 178 | 36 | 3 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-04 | 178 | 36 | 3 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.01e-04 | 179 | 36 | 3 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 4.01e-04 | 179 | 36 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 6.65e-04 | 34 | 33 | 2 | EFO_0004458, EFO_0004612 | |
| Disease | apolipoprotein B measurement | 7.95e-04 | 663 | 33 | 5 | EFO_0004615 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.06e-03 | 43 | 33 | 2 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.06e-03 | 43 | 33 | 2 | EFO_0022254 | |
| Disease | dimethylglycine measurement | 1.22e-03 | 46 | 33 | 2 | EFO_0010476 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.38e-03 | 49 | 33 | 2 | EFO_0022256 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.44e-03 | 200 | 33 | 3 | EFO_0004611, EFO_0020945 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.49e-03 | 51 | 33 | 2 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.49e-03 | 51 | 33 | 2 | EFO_0022242 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 1.61e-03 | 53 | 33 | 2 | EFO_0008464 | |
| Disease | total lipids in medium VLDL | 1.67e-03 | 54 | 33 | 2 | EFO_0022153 | |
| Disease | triglycerides in medium VLDL measurement | 1.74e-03 | 55 | 33 | 2 | EFO_0022155 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.74e-03 | 55 | 33 | 2 | EFO_0022234 | |
| Disease | isoleucine measurement | 1.80e-03 | 56 | 33 | 2 | EFO_0009793 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.93e-03 | 58 | 33 | 2 | EFO_0022338 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.94e-03 | 222 | 33 | 3 | EFO_0008317, EFO_0020943 | |
| Disease | cholesterol in medium HDL measurement | 1.99e-03 | 59 | 33 | 2 | EFO_0021903 | |
| Disease | phospholipids in VLDL measurement | 1.99e-03 | 59 | 33 | 2 | EFO_0022301 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.02e-03 | 225 | 33 | 3 | EFO_0008317, EFO_0020947 | |
| Disease | total lipids in VLDL measurement | 2.06e-03 | 60 | 33 | 2 | EFO_0022314 | |
| Disease | phospholipids:total lipids ratio | 2.07e-03 | 227 | 33 | 3 | EFO_0020946 | |
| Disease | free cholesterol in VLDL measurement | 2.13e-03 | 61 | 33 | 2 | EFO_0022276 | |
| Disease | triglycerides in medium LDL measurement | 2.20e-03 | 62 | 33 | 2 | EFO_0022322 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.27e-03 | 63 | 33 | 2 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.27e-03 | 63 | 33 | 2 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 2.34e-03 | 64 | 33 | 2 | EFO_0022253 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.39e-03 | 239 | 33 | 3 | EFO_0008317, EFO_0020945 | |
| Disease | triglycerides in small LDL measurement | 2.41e-03 | 65 | 33 | 2 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 2.41e-03 | 65 | 33 | 2 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 2.41e-03 | 65 | 33 | 2 | EFO_0022230 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.51e-03 | 243 | 33 | 3 | EFO_0004612, EFO_0020944 | |
| Disease | total lipids in small VLDL | 2.56e-03 | 67 | 33 | 2 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 2.56e-03 | 67 | 33 | 2 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 2.64e-03 | 68 | 33 | 2 | EFO_0022265 | |
| Disease | Abdominal Aortic Aneurysm | 2.64e-03 | 68 | 33 | 2 | EFO_0004214 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.72e-03 | 69 | 33 | 2 | EFO_0022341 | |
| Disease | cholesterol in very large HDL measurement | 2.72e-03 | 69 | 33 | 2 | EFO_0022229 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 3.12e-03 | 74 | 33 | 2 | EFO_0022280 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.17e-03 | 264 | 33 | 3 | EFO_0008317, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STNCSSKCKGHAVCD | 626 | Q9UKQ2 | |
| DPDCNKTSGECHCKE | 1896 | Q9HCU4 | |
| GKSKTCCENKEEKCC | 391 | Q8N884 | |
| LCSKCSPHFSDCKKS | 311 | O95905 | |
| DKENPSGCSECKCHK | 621 | Q16787 | |
| SGCSECKCHKAGTVS | 626 | Q16787 | |
| SHCDCCCKNGKGDKE | 286 | Q68DU8 | |
| KTKDTHPESCCSSEK | 576 | Q9H3C7 | |
| GEGEKFNCEKCHESC | 1661 | Q92824 | |
| DESQKNCLKCHPSCK | 791 | P29122 | |
| NCLKCHPSCKKCVDE | 796 | P29122 | |
| KAQALDHSCSCCKEE | 5111 | Q02817 | |
| DHSCSCCKEEKTSQR | 5116 | Q02817 | |
| LTKTECEACNCHGKA | 336 | P24043 | |
| VAKACDEGHCTAKDC | 346 | P26440 | |
| KKHPDVSCDNCCKTK | 1056 | P54132 | |
| PSCTESDSCKRDCKK | 451 | A8MUX0 | |
| SCMNKDHGCSHICKE | 176 | Q9NQ36 | |
| TKEKKHQCDHCERCF | 151 | Q9UM63 | |
| CKDGCRDKSKCACHQ | 731 | Q15047 | |
| KCKECGKCFTQNSHL | 291 | Q9H7R5 | |
| CHKDSDCSGKKRCCH | 96 | Q8TCV5 | |
| PNSEEKCHKCEECGK | 141 | O75820 | |
| QKIHTGEKSCKCEKC | 206 | Q8NDQ6 | |
| DKCKCCRFANKDTHL | 261 | A4D1E1 | |
| GEKSHECTECGKVCS | 51 | Q3ZCT1 | |
| KCLSKSQQCNGKDDC | 536 | Q9Y5Y6 | |
| KCHTGEKSFECKECG | 216 | Q6ZNG0 | |
| AKSYECKECGKACNH | 436 | Q9NQX6 | |
| DINKCTKCKADCDTC | 91 | Q9BXY4 | |
| AEEDTDSKFKCKLCC | 986 | Q9NRE2 | |
| ECKECGKTFCQKSHL | 871 | Q9BY31 | |
| ELSSKSKCFCENCGK | 221 | Q3LFD5 | |
| THTTEKACECKECGK | 111 | P17030 | |
| SHQCQECGKKLSCSS | 281 | Q8IZC7 | |
| EKACKCNECGKAFSQ | 366 | Q8NF99 | |
| KSTHSGEKNCKCDEC | 216 | Q8NB50 | |
| ELSSKSKCFCENCGK | 221 | Q9UMW8 | |
| TCECQECTTKDKDKA | 261 | Q9NRG4 | |
| HTGEKPCECSKCNKA | 306 | Q0D2J5 |